Opus Genetics, Inc. Operating Leases, Rent Expense
Opus Genetics, Inc. (IRD) reported Operating Leases, Rent Expense of $48.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-05-07
- Opus Genetics, Inc. operating leases, rent expense for the quarter ending 2021-03-31 was $48.00K, a 433.33% increase year-over-year.
- Opus Genetics, Inc. operating leases, rent expense for the quarter ending 2020-03-31 was $9.00K.
- Opus Genetics, Inc. operating leases, rent expense for fiscal 2020 was $54.00K, a 170.00% increase from fiscal 2019.
- Opus Genetics, Inc. operating leases, rent expense for fiscal 2019 was $20.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 12 month |
|---|---|---|
| 2021-03-31 | $48.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $54.00K 10-K · filed 2021-03-11 | |
| 2020-03-31 | $9.00K 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |